Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-22-051544

Chief Financial Officer sold 443 shares at $22.73 ($10,069)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Catinazzo Thomas Chief Financial Officer 2022-09-27 Sale −443 $22.73 $10,069 51,775 D
Open-market sales · 443 sh · avg $22.73 · $10,069
Loading xslF345X03/doc4.xml…